CTNNB1 clinical trials at UCSF

1 research study open to eligible people

CTNNB1 is a gene that helps cells stick together and send signals. UCSF is enrolling people with advanced or metastatic solid tumors in drug studies. Staff track side effects and tumor size.

FOG-001 in Locally Advanced or Metastatic Solid Tumors
open to eligible people ages 18 years and up
The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic cancer.
San Francisco, California and other locations

Last updated: January 8, 2026